Furthermore, patients with PD-L1-positive tumor cells accompanied by low PD-1-positive TIL counts exhibited poorer prognosis compared to those with PD-L1-negative DLBCL and high PD-1-positive TIL counts (219). The gene discussed is RPL17; the disease is neoplasm.